住院患者静脉血栓栓塞症预防护理与管理专家共识

2021-06-30 国际血管联盟 解放军护理杂志.2021.38(6):17-21.

静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺血栓栓塞症(PTE),是仅次于心肌梗死和脑卒中的第三大最常见的心血管疾病,也是住院患者医院内可预防的死亡原因之一。目前,各级医院逐渐加强对VTE

中文标题:

住院患者静脉血栓栓塞症预防护理与管理专家共识

发布机构:

国际血管联盟

发布日期:

2021-06-30

简要介绍:

静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺血栓栓塞症(PTE),是仅次于心肌梗死和脑卒中的第三大最常见的心血管疾病,也是住院患者医院内可预防的死亡原因之一。目前,各级医院逐渐加强对VTE预防护理的关注,但国内外相关调查表明,VTE预防护理与管理仍存在缺陷。因此,国际血管联盟中国分部血栓预防医护专家依据国内外指南及循证医学证据,结合临床经验对VTE预防护理与管理相关内容进行总结,形成专家共识。执笔作者在查阅国内外相关指南、构建基于循证的VE预防护理方案的基础上拟定共识初稿,通过专家讨论修改完善,形成终稿,旨在为提高VTE预防护理与管理临床实践的规范性提供参考依据。

相关资料下载:
[AttachmentFileName(sort=1, fileName=住院患者静脉血栓栓塞症预防护理与管理专家共识_植艳茹.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a32a21c0021a167e, title=住院患者静脉血栓栓塞症预防护理与管理专家共识, enTitle=, guiderFrom=解放军护理杂志.2021.38(6):17-21., authorId=0, author=, summary=静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺血栓栓塞症(PTE),是仅次于心肌梗死和脑卒中的第三大最常见的心血管疾病,也是住院患者医院内可预防的死亡原因之一。目前,各级医院逐渐加强对VTE, cover=https://img.medsci.cn/2021731/1627738577619_2020535.jpg, journalId=0, articlesId=null, associationId=1013, associationName=国际血管联盟, associationIntro=国际血管联盟(International Union of Angiology, IUA),创建于1950年。这是一个以血管外科医师为主导的血管相关学科医师参与的大型国际学术组织。目前拥有73个国家的数千名会员,每2年在世界各地召开国际学术活动,积极开展相关的学术交流。, copyright=0, guiderPublishedTime=Wed Jun 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>静脉血栓栓塞症(VTE)包括深静脉血栓形成(DVT)和肺血栓栓塞症(PTE),是仅次于心肌梗死和脑卒中的第三大最常见的心血管疾病,也是住院患者医院内可预防的死亡原因之一。目前,各级医院逐渐加强对VTE预防护理的关注,但国内外相关调查表明,VTE预防护理与管理仍存在缺陷。因此,国际血管联盟中国分部血栓预防医护专家依据国内外指南及循证医学证据,结合临床经验对VTE预防护理与管理相关内容进行总结,形成专家共识。执笔作者在查阅国内外相关指南、构建基于循证的VE预防护理方案的基础上拟定共识初稿,通过专家讨论修改完善,形成终稿,旨在为提高VTE预防护理与管理临床实践的规范性提供参考依据。</p> </div> </div> </div>, tagList=[TagDto(tagId=582, tagName=静脉血栓)], categoryList=[CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=582, guiderKeyword=静脉血栓, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13406, appHits=1247, showAppHits=0, pcHits=2592, showPcHits=12158, likes=5, shares=120, comments=20, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 31 21:36:29 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:23:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=住院患者静脉血栓栓塞症预防护理与管理专家共识_植艳茹.pdf)])
住院患者静脉血栓栓塞症预防护理与管理专家共识_植艳茹.pdf
下载请点击:
评论区 (19)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2115502, encodeId=ae8b2115502f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/8af58a8d80fa4d3e83e7cc9686930f6e/4638f64094bd40a4bb51a09cacaee275.jpg, createdBy=33335378595, createdName=ms9000001531324985, createdTime=Mon Feb 20 11:52:33 CST 2023, time=2023-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2095980, encodeId=0a0220959804d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15283017431, createdName=zhangz3303, createdTime=Tue Oct 25 09:26:21 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248456, encodeId=a5b0124845625, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/90cd78a8836f465faf5266e4028b9439/cb08654c2cbc476d9fc4d0611dfff571.jpg, createdBy=549e5489940, createdName=ms2000001715326967, createdTime=Mon Sep 12 01:06:14 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218097, encodeId=32f2121809ea8, content=学习学习~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=学者, createdTime=Mon May 09 11:23:12 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200435, encodeId=e40d120043502, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:25:00 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2023-02-20 ms9000001531324985 来自江苏省

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2115502, encodeId=ae8b2115502f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/8af58a8d80fa4d3e83e7cc9686930f6e/4638f64094bd40a4bb51a09cacaee275.jpg, createdBy=33335378595, createdName=ms9000001531324985, createdTime=Mon Feb 20 11:52:33 CST 2023, time=2023-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2095980, encodeId=0a0220959804d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15283017431, createdName=zhangz3303, createdTime=Tue Oct 25 09:26:21 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248456, encodeId=a5b0124845625, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/90cd78a8836f465faf5266e4028b9439/cb08654c2cbc476d9fc4d0611dfff571.jpg, createdBy=549e5489940, createdName=ms2000001715326967, createdTime=Mon Sep 12 01:06:14 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218097, encodeId=32f2121809ea8, content=学习学习~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=学者, createdTime=Mon May 09 11:23:12 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200435, encodeId=e40d120043502, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:25:00 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-10-25 zhangz3303

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2115502, encodeId=ae8b2115502f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/8af58a8d80fa4d3e83e7cc9686930f6e/4638f64094bd40a4bb51a09cacaee275.jpg, createdBy=33335378595, createdName=ms9000001531324985, createdTime=Mon Feb 20 11:52:33 CST 2023, time=2023-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2095980, encodeId=0a0220959804d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15283017431, createdName=zhangz3303, createdTime=Tue Oct 25 09:26:21 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248456, encodeId=a5b0124845625, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/90cd78a8836f465faf5266e4028b9439/cb08654c2cbc476d9fc4d0611dfff571.jpg, createdBy=549e5489940, createdName=ms2000001715326967, createdTime=Mon Sep 12 01:06:14 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218097, encodeId=32f2121809ea8, content=学习学习~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=学者, createdTime=Mon May 09 11:23:12 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200435, encodeId=e40d120043502, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:25:00 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-09-12 ms2000001715326967

    受用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2115502, encodeId=ae8b2115502f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/8af58a8d80fa4d3e83e7cc9686930f6e/4638f64094bd40a4bb51a09cacaee275.jpg, createdBy=33335378595, createdName=ms9000001531324985, createdTime=Mon Feb 20 11:52:33 CST 2023, time=2023-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2095980, encodeId=0a0220959804d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15283017431, createdName=zhangz3303, createdTime=Tue Oct 25 09:26:21 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248456, encodeId=a5b0124845625, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/90cd78a8836f465faf5266e4028b9439/cb08654c2cbc476d9fc4d0611dfff571.jpg, createdBy=549e5489940, createdName=ms2000001715326967, createdTime=Mon Sep 12 01:06:14 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218097, encodeId=32f2121809ea8, content=学习学习~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=学者, createdTime=Mon May 09 11:23:12 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200435, encodeId=e40d120043502, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:25:00 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-05-09 学者

    学习学习~

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2115502, encodeId=ae8b2115502f3, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/8af58a8d80fa4d3e83e7cc9686930f6e/4638f64094bd40a4bb51a09cacaee275.jpg, createdBy=33335378595, createdName=ms9000001531324985, createdTime=Mon Feb 20 11:52:33 CST 2023, time=2023-02-20, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2095980, encodeId=0a0220959804d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15283017431, createdName=zhangz3303, createdTime=Tue Oct 25 09:26:21 CST 2022, time=2022-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1248456, encodeId=a5b0124845625, content=受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/90cd78a8836f465faf5266e4028b9439/cb08654c2cbc476d9fc4d0611dfff571.jpg, createdBy=549e5489940, createdName=ms2000001715326967, createdTime=Mon Sep 12 01:06:14 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218097, encodeId=32f2121809ea8, content=学习学习~, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201128/8bd43ecc40d747e890c41c35a068882e/9f274b8360b04bf085fc42125c37f102.jpg, createdBy=c4bc5437608, createdName=学者, createdTime=Mon May 09 11:23:12 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200435, encodeId=e40d120043502, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Mar 08 05:25:00 CST 2022, time=2022-03-08, status=1, ipAttribution=)]
    2022-03-08 genglihui01

    学习

    0

拓展阅读

2014 ASCO 癌症患者静脉血栓栓塞防治指南(更新版)

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2015-01-20

2015 ACFAS临床共识声明:需要进行固定的足踝部手术以及外伤静脉血栓血栓栓塞疾病的危险因素,预防和诊断

美国足踝外科医师协会(ACFAS,American College of Foot and Ankle Surgeons) · 2015-03-19

NCS:2015 预防神经重症监护患者静脉血栓指南

美国神经重症监护学会(NCS,Neurocritical Care Society) · 2015-05-14

2015 BCSH指南:肿瘤相关静脉血栓形成

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2015-06-26

2016 妊娠相关静脉血栓栓塞症的诊断共识

国外妇产科相关专家组 · 2016-08-10